BDBM105148 US8569281, 175
SMILES: Cn1cccc(Nc2n[nH]c3ccnc(OC4CCOCC4)c23)c1=O
InChI Key: InChIKey=NDCINVDYIZBLBH-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM105148 (US8569281, 175) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Research Council Technology; Genentech, Inc. US Patent | Assay Description This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values. | US Patent US8569281 (2013) BindingDB Entry DOI: 10.7270/Q2DN43PM | |||||||||||
More data for this Ligand-Target Pair |